Literature DB >> 27321363

Antibiotic duration and timing of the switch from intravenous to oral route for bacterial infections in children: systematic review and guidelines.

Brendan J McMullan1, David Andresen2, Christopher C Blyth3, Minyon L Avent4, Asha C Bowen5, Philip N Britton6, Julia E Clark7, Celia M Cooper8, Nigel Curtis9, Emma Goeman10, Briony Hazelton11, Gabrielle M Haeusler12, Ameneh Khatami13, James P Newcombe10, Joshua Osowicki14, Pamela Palasanthiran1, Mike Starr15, Tony Lai16, Clare Nourse7, Joshua R Francis17, David Isaacs6, Penelope A Bryant18.   

Abstract

Few studies are available to inform duration of intravenous antibiotics for children and when it is safe and appropriate to switch to oral antibiotics. We have systematically reviewed antibiotic duration and timing of intravenous to oral switch for 36 paediatric infectious diseases and developed evidence-graded recommendations on the basis of the review, guidelines, and expert consensus. We searched databases and obtained information from references identified and relevant guidelines. All eligible studies were assessed for quality. 4090 articles were identified and 170 studies were included. Evidence relating antibiotic duration to outcomes in children for some infections was supported by meta-analyses or randomised controlled trials; in other infections data were from retrospective series only. Criteria for intravenous to oral switch commonly included defervescence and clinical improvement with or without improvement in laboratory markers. Evidence suggests that intravenous to oral switch can occur earlier than previously recommended for some infections. We have synthesised recommendations for antibiotic duration and intravenous to oral switch to support clinical decision making and prospective research.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27321363     DOI: 10.1016/S1473-3099(16)30024-X

Source DB:  PubMed          Journal:  Lancet Infect Dis        ISSN: 1473-3099            Impact factor:   25.071


  38 in total

1.  Pyogenic sacroiliitis in children: don't forget the very young.

Authors:  Eran Lavi; Alex Gileles-Hillel; Natalia Simanovsky; Dina Averbuch; Isaiah D Wexler; Yackov Berkun
Journal:  Eur J Pediatr       Date:  2019-02-07       Impact factor: 3.183

2.  Surviving sepsis campaign international guidelines for the management of septic shock and sepsis-associated organ dysfunction in children.

Authors:  Scott L Weiss; Mark J Peters; Waleed Alhazzani; Michael S D Agus; Heidi R Flori; David P Inwald; Simon Nadel; Luregn J Schlapbach; Robert C Tasker; Andrew C Argent; Joe Brierley; Joseph Carcillo; Enitan D Carrol; Christopher L Carroll; Ira M Cheifetz; Karen Choong; Jeffry J Cies; Andrea T Cruz; Daniele De Luca; Akash Deep; Saul N Faust; Claudio Flauzino De Oliveira; Mark W Hall; Paul Ishimine; Etienne Javouhey; Koen F M Joosten; Poonam Joshi; Oliver Karam; Martin C J Kneyber; Joris Lemson; Graeme MacLaren; Nilesh M Mehta; Morten Hylander Møller; Christopher J L Newth; Trung C Nguyen; Akira Nishisaki; Mark E Nunnally; Margaret M Parker; Raina M Paul; Adrienne G Randolph; Suchitra Ranjit; Lewis H Romer; Halden F Scott; Lyvonne N Tume; Judy T Verger; Eric A Williams; Joshua Wolf; Hector R Wong; Jerry J Zimmerman; Niranjan Kissoon; Pierre Tissieres
Journal:  Intensive Care Med       Date:  2020-02       Impact factor: 17.440

Review 3.  Recent Advances in Oral Nano-Antibiotics for Bacterial Infection Therapy.

Authors:  Ze-Liang Wu; Jun Zhao; Rong Xu
Journal:  Int J Nanomedicine       Date:  2020-12-01

Review 4.  Medication and Fluid Management of Pediatric Sepsis and Septic Shock.

Authors:  Lauren Burgunder; Caroline Heyrend; Jared Olson; Chanelle Stidham; Roni D Lane; Jennifer K Workman; Gitte Y Larsen
Journal:  Paediatr Drugs       Date:  2022-03-21       Impact factor: 3.022

5.  Epidemiology, Diagnosis, and Treatment of Clostridioides difficile Infection in Immunocompromised Children.

Authors:  Shane J Cross; Theodore H Morton; Joshua Wolf
Journal:  J Pediatric Infect Dis Soc       Date:  2021-11-17       Impact factor: 3.164

Review 6.  Optimal antimicrobial duration for common bacterial infections.

Authors:  Heather L Wilson; Kathryn Daveson; Christopher B Del Mar
Journal:  Aust Prescr       Date:  2019-02-01

7.  Opportunities for Stewardship in the Transition From Intravenous to Enteral Antibiotics in Hospitalized Pediatric Patients.

Authors:  Jillian M Cotter; Matt Hall; Sonya Tang Girdwood; John R Stephens; Jessica L Markham; James C Gay; Samir S Shah
Journal:  J Hosp Med       Date:  2021-02       Impact factor: 2.960

8.  Prediction of Adverse Outcomes in Pediatric Acute Hematogenous Osteomyelitis.

Authors:  Zaid Alhinai; Morvarid Elahi; Sangshin Park; Bill Foo; Brian Lee; Kimberle Chapin; Michael Koster; Pablo J Sánchez; Ian C Michelow
Journal:  Clin Infect Dis       Date:  2020-12-03       Impact factor: 9.079

9.  Paediatric Common Infections Pathways: improving antimicrobial stewardship and promoting ambulation for children presenting with common infections to hospitals in the UK and Ireland.

Authors:  Carolyne Horner; Robert Cunney; Alicia Demirjian; Conor Doherty; Helen Green; Mathew Mathai; Paddy McMaster; Alasdair Munro; Stéphane Paulus; Damian Roland; Sanjay Patel
Journal:  JAC Antimicrob Resist       Date:  2021-03-12

Review 10.  Updated good practice recommendations for outpatient parenteral antimicrobial therapy (OPAT) in adults and children in the UK.

Authors:  Ann L N Chapman; Sanjay Patel; Carolyne Horner; Helen Green; Achyut Guleri; Sara Hedderwick; Susan Snape; Julie Statham; Elizabeth Wilson; Mark Gilchrist; R Andrew Seaton
Journal:  JAC Antimicrob Resist       Date:  2019-08-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.